Clinicoepidemiological characterization of patients with tuberculosis treated in a hospital of East Timor
Keywords:
TUBERCULOSIS, RISK FACTORS, CLINICAL DIAGNOSIS, THERAPEUTICS.Abstract
Background: tuberculosis is the main health problem in East Timor.
Objective: to characterize clinically and epidemiologically patients with pulmonary and extrapulmonary tuberculosis treated at the Referral Hospital of Maubisse, East Timor, from January 2015 to December 2016.
Methods: a descriptive cross-sectional research was carried out. The population was made up of 168 patients, of 15 years of age and older, with a clinicoradiologic or microbiological diagnosis of pulmonary tuberculosis, or with a clinical diagnosis of extrapulmonary tuberculosis, made by using other means. The patients had been admitted to the aforementioned hospital during the period herein declared. The data obtained from the measured variables were analyzed according to descriptive statistics.
Results: the majority of the patients were female (58,3 %) and younger than 35 years of age (42,2 %). Among the associated risk factors, overcrowding (95,2 %), contact with people with TB (91 %) and chronic malnutrition (81,5 %) prevailed. The main signs and symptoms found were asthenia (93,4 %), weight loss (86,3 %), malnutrition (81,5 %), night sweats (73,8 %), dry cough (64,9 %) and anorexia (52,9 %). Sputum culture was positive only in a few patients (3,6 %). Most of the patients (86,3 %) responded positively to therapy.
Conclusions: the clinical and epidemiological variables in the studied population were characterized. The patients responded positively to treatment.
Downloads
References
Noya Chaveco ME, Moya Gonzáles NL. Tuberculosis pulmonar. En: Roca Goderich R. Temas de medicina interna. 5 ed. La Habana: ECIMED; 2017. p. 269-83.
Muñoz Sánchez AI, García Alvarado CA. Programa de control de la tuberculosis: una mirada desde los trabajadores de la salud. Inv Enf Imag Des [revista en internet]. 2016 [citado 8 de febrero 2018]; 18(2): 121-35. Disponible en: http://dx.doi.org/10.11144/Javeriana.ie18-2.pctm.
Ellnnaer JJ. Tuberculosis. En: Golman L, Schafer AI. Tratado de medicina interna. 24 ed. Barcelona: ELSERVIER; 2013. p. 1943-52.
García García JM, Palacios Gutiérrez JJ. Tuberculosis pulmonar: etiología, patogenia, epidemiología, clínica y diagnóstico. En: Álvarez Sala W. Neumología clínica. Barcelona: ELSEVIER; 2010. P. 322-30.
Organización Mundial de la Salud. Poner fin a la tuberculosis en la era del desarrollo sostenible: Una respuesta multisectorial. Moscú (Federación de Rusia), 16-17 de noviembre de 2017. Primera Conferencia Ministerial Mundial de la OMS [citado 8 de febrero 2018]. Disponible en: http://www.who.int/tb/ publications/global.report/es/.
Hernández Mahecha G, Mosquera Arboleda Y, Vélez Vanegas C, Montes FN. Factores asociados al desarrollo de tuberculosis en contactos domiciliarios de pacientes con tuberculosis, Medellín 2015. Rev CES Salud Pública [revista en internet]. 2017 [citado 8 de febrero 2018]; 8(1): 48-60. Disponible en: http://revistas.ces.edu.co/index.php/ces_salud_publica/article/view/3732.
Compendium of WHO guidelines and associated standards: ensuring optimum delivery of the cascade of care for patients with TB; 2016 [citado 8 de febrero 2018]. Disponible en: http://www.who.int/tb/publica tions/digitalhealth-TB-agenda/en/.
López Palacio JD. Determinantes sociales de la salud en pacientes con tuberculosis. Manizales, Colombia. 2012-2013. Arch Med [revista en internet]. 2017 [citado 8 de febrero 2018]; 17(1): 2339-74. Disponible en: http://www.redalyc.org/html/2738/273851831005/.
Lavania S, Anthwal D, Bhalla M, Singh N, Haldar S, Tyagi JS. Direct detection of Mycobacterium tuberculosis rifampin resistance in bio-safe stained sputum smears. PLoS ONE [revista en internet]. 2017 [citado 8 de febrero 2018]; 12(12): e0189149. Disponible en: https://doi.org/10.1371/journal.
United Nations Development Programmer, Timor-Leste Country Office. 2008-2010.
Organización Mundial de la Salud. Informe mundial sobre la tuberculosis 2016. [citado 8 de febrero 2018]. Disponible en: http://www.who.int/tb/publications/global.report/en/.
Maciel ES, Amancio JS, Castro DB, Braga JU. Social determinants of pulmonary tuberculosis treatment non-adherence in Rio de Janeiro, Brazil. PLoS ONE [revista en internet]. 2017 [citado 8 de febrero 2018]; 13(1): e0190578. Disponible en: https://doi.org/10.1371/journal.
Alarcón V, Alarcón E, Figueroa C, Mendoza Ticona A. Tuberculosis en el perú: Situación epidemiológica, avances y desafíos para su control. Rev Peruana Med. Experim. Sa.l Púb. [revista en internet]. 2017 [citado 8 de febrero 2018]; 34(2): 299-310. Disponible en: https://rpmesp.ins.gob.pe/index.php/rpmesp/ article/view/2384/2777.
Center for Disease Control and Prevention. Tuberculosis. Atlanta: CDC; 2017 [citado 22 de julio 2017]. Disponible en: https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-totravel/tubercu losis.
UNICEF. Informe de Acción Humanitaria 2009. Asia y el Pacífico [en línea] Timor Leste: Resumen de la situación de emergencia [citado 13 de diciembre 2009] Disponible en: http://www.unicef.org/spanish/har 09/index_timor-leste.php.
Marrero Rodríguez H, Quintero Salcedo S. Factores de riesgo de la tuberculosis pulmonar en pacientes timorenses. Medisan [revista en internet]. 2018 [citado 8 de febrero 2018]; 22(1): 60-7. Disponible en: http://medisan.sld.cu/index.php/san/article/view/1707.
Brandy O. The clinical presentation of tuberculosis. Prev Respir [revista en internet]. 1998 [citado 8 de febrero 2018]; 65(2): 97-105. Disponible en: https://www.karger.com/Article/Abstract/29238.
World Health Organization. Global tuberculosis control: surveillance, planning, financing. Geneva: WHO; 2006. P. 242.
Abebe F, Belay M, Legesse M, Ottenhoff T. IgA and IgG against Mycobacterium tuberculosis Rv2031 discriminate between pulmonary tuberculosis patients, Mycobacterium tuberculosis-infected and non-infected individuals. Plos ONE [revista en internet]. 2018 [citado 8 de febrero 2018]; 13(1): 1-19. Disponible en: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0190989.
McCarthy K, Churchyard G, Fielding K, Grant A. Empiric tuberculosis treatment in South African primary health care facilities-for whom, where, when and why: Implications for the development of tuberculosis diagnostic tests. Plos ONE [revista en internet]. 2018 [citado 8 de febrero 2018]; 13(1): 1-14. Disponible en: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0191608.
Famewo E, Clarke A, Afolayan A. Ethno-medicinal documentation of polyherbal medicines used for the treatment of tuberculosis in Amathole District Municipality of the Eastern Cape Province, South Africa. Pharmac Biol [revista en internet]. 2017 [citado 8 de febrero 2018]; 55(1): 696-700. Disponible en: https://www.tandfonline.com/doi/abs/10.1080/13880209.2016.1266670.
Parlato S, Romagnoli G, Canini I, Gabriele L, Chiacchio T, Castiello L, et al. Impaired IFN-α-mediated signal in dendritic cells differentiates active from latent tuberculosis. Plos ONE [revista en internet]. 2018 [citado 8 de febrero 2018]; 13(1): 1-18. Disponible en: http://journals.plos.org/plosone/article?id=10.1371/journal. pone.0189477.
Mupfumi L, Moyo S, Molebatsi K, Thami P, Anderson M, Gaseitsiwe S, et al. Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana. Plos ONE [revista en internet]. 2018 [citado 8 de febrero 2018]; 13(1): 1-13. Disponible en: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0192030.
Maciel E, Amancio J, Castro D, Braga J. Social determinants of pulmonary tuberculosis treatment non-adherence in Rio de Janeiro, Brazil. Plos ONE [revista en internet]. 2018, Enero [citado 8 de febrero 2018]; 13(1): 1-14. Disponible en: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0190578.
Lih Yu C, Chih Hsin L, Chia Hao C, Ming Chia L, Meng Rui L, Li Na L, et al. Acute biliary events during anti-tuberculosis treatment: hospital case series and a nationwide cohort study. BMC Infect Dis [revista en internet]. 2018, Febr [citado 8 de febrero 2018]; 18(1): 8. Disponible en: https://bmcinfectdis.biomed central.com/articles/10.1186/s12879-018-2966-3.
Downloads
Published
How to Cite
Issue
Section
License
This journal provides free and immediate access to its content under the principle that making research freely available to the public supports a greater exchange of global knowledge. This means that the authors transfer the copyright to the journal, so that copies and distribution of the contents can be made by any means, as long as the authors' acknowledgment is maintained. These terms are a reflection that the journal assumes copyright under Creative Commons licenses, specifically under a Creative Commons Attribution 4.0 International license.
Registration and submission of articles to the journal is free. The processing, including review, editing and publication, is completely free of charge.